ERBB2 and choriocarcinoma: Additionally, in vitro studies have demonstrated that trastuzumab and Lapatinib® significantly reduce proliferation and induce apoptosis in choriocarcinoma cell lines (JEG3 and BeWo) through HER2 blockade.34